Cargando…

Systemic characterization of alternative splicing related to prognosis, immune infiltration, and drug sensitivity analysis in ovarian cancer

BACKGROUND: Alternative splicing (AS) plays an essential role in tumorigenesis and progression. This study intended to construct an innovative prognostic model based on AS events to gain more precise survival prediction and search for potential therapeutic targets in ovarian cancer. METHODS: Seven t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Qingyang, Zhang, Hao, Yang, Xiaocheng, Liu, Xuesong, Yin, Fanxing, Guo, Panpan, Yin, Yuhan, Zheng, Kaijiang, Yang, Zhuo, Han, Yanshuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article on New Progress and Challenge in Gynecological Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848412/ https://www.ncbi.nlm.nih.gov/pubmed/35282039 http://dx.doi.org/10.21037/atm-21-6422

Ejemplares similares

Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer
por: Yang, Xiaocheng, et al.
Publicado: (2022)

Identifying the Role of Oxidative Stress-Related Genes as Prognostic Biomarkers and Predicting the Response of Immunotherapy and Chemotherapy in Ovarian Cancer
por: Liu, Qingyang, et al.
Publicado: (2022)

New progress and challenge in gynecological cancer
por: Wang, Danbo
Publicado: (2022)

Management of stage I occult uterine leiomyosarcoma: effects of morcellation, second-look surgery, and adjuvant treatments on survival
por: Yang, Jie, et al.
Publicado: (2022)

Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study
por: Li, Zhiqiang, et al.
Publicado: (2022)

Value of diffusion-weighted imaging in preoperative evaluation and prediction of postoperative supplementary therapy for patients with cervical cancer
por: Liu, Liying, et al.
Publicado: (2022)

Efficacy evaluation of vaginal-assisted laparoscopic radical hysterectomy and laparoscopic radical hysterectomy for cervical cancer: a single-center retrospective case series study
por: Wang, Huimin, et al.
Publicado: (2022)

Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study
por: Chen, Xiaolin, et al.
Publicado: (2022)

Establishment of a molecular risk model for the prognosis of cervical cancer based on microRNA expression
por: Li, Jian, et al.
Publicado: (2022)

Alternative splicing: a paradoxical qudo in eukaryotic genomes
por: Kashyap, Luv, et al.
Publicado: (2007)

Alternative Splicing: A New Therapeutic Target for Ovarian Cancer
por: Yao, Shijie, et al.
Publicado: (2022)

Systemic Inflammatory Markers for Predicting Overall Survival in Patients with Osteosarcoma: A Systematic Review and Meta-Analysis
por: Song, Xiaotong, et al.
Publicado: (2021)

A combined clinical and genetic model for predicting risk of ovarian cancer
por: Dite, Gillian S., et al.
Publicado: (2022)

Comprehensive Analysis of Key m6A Modification Related Genes and Immune Infiltrates in Human Aortic Dissection
por: Yin, Fanxing, et al.
Publicado: (2022)

Cell therapies in ovarian cancer
por: Sarivalasis, Apostolos, et al.
Publicado: (2021)

Identification of survival-related alternative splicing signatures in acute myeloid leukemia
por: Zhang, Biyu, et al.
Publicado: (2021)

An interactive network of alternative splicing events with prognostic value in geriatric lung adenocarcinoma via the regulation of splicing factors
por: Wang, Yidi, et al.
Publicado: (2020)

CircRNA-Based Cervical Cancer Prognosis Model, Immunological Validation and Drug Prediction
por: Guo, Xu, et al.
Publicado: (2022)

Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in human aortic dissection
por: Zhang, Hao, et al.
Publicado: (2021)

Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer
por: Doo, David W., et al.
Publicado: (2020)

Identification of prognostic and bone metastasis‐related alternative splicing signatures in mesothelioma
por: Huang, Runzhi, et al.
Publicado: (2021)

Current Situation and Prospect of Adoptive Cellular Immunotherapy for Malignancies
por: Zhao, Dong, et al.
Publicado: (2023)

Immune checkpoint inhibitors in ovarian cancer: where do we stand?
por: Leary, Alexandra, et al.
Publicado: (2021)

Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer
por: Chen, Jiang, et al.
Publicado: (2022)

Health Disparities in Ovarian Cancer: Report From the Ovarian Cancer Evidence Review Conference
por: Mei, Shirley, et al.
Publicado: (2023)

Construction of the circRNA-miRNA-mRNA Regulatory Network of an Abdominal Aortic Aneurysm to Explore Its Potential Pathogenesis
por: Zhang, Hao, et al.
Publicado: (2021)

Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)

Patterns of Care and Outcomes for Small Cell Carcinoma of the Cervix: A National Retrospective Analysis of 542 Cases
por: Wharton, David, et al.
Publicado: (2019)

The Impact of High-Dose-Rate Brachytherapy: Measuring Clinical Outcomes in the Primary Treatment of Cervical Cancer
por: Song, Jiheon, et al.
Publicado: (2020)

Is there an alternative to increasing the sample size in microarray studies?
por: Klebanov, Lev, et al.
Publicado: (2007)

Wide complex tachycardia with alternating ventriculoatrial conduction
por: Pilecky, David, et al.
Publicado: (2023)

Executive Summary of the Ovarian Cancer Evidence Review Conference
por: Burke, William, et al.
Publicado: (2023)

Integrated bioinformatic analysis of dysregulated microRNA‐mRNA co‐expression network in ovarian endometriosis
por: Liu, Yong, et al.
Publicado: (2022)

Alternative iliofemoral revascularization in extensive aortoiliac occlusive disease
por: Giusti, Júlio César Gomes, et al.
Publicado: (2019)

Alternative treatment for patent ductus arteriosus: a therapeutic challenge
por: Domenighi, Lauro Henrique Heinsch, et al.
Publicado: (2021)

Chemo-immunotherapy as first-line treatment for small-cell lung cancer
por: Farid, Saira, et al.
Publicado: (2020)

The application of risk models based on machine learning to predict endometriosis‐associated ovarian cancer in patients with endometriosis
por: Chao, Xiaopei, et al.
Publicado: (2022)

TGFBR2 mutation predicts resistance to immune checkpoint inhibitors in patients with non-small cell lung cancer
por: Li, Teng, et al.
Publicado: (2021)

Early identification of recurrence in ovarian cancer: a comparison between the ovarian cancer metastasis index and CA-125 levels
por: Wang, Fei, et al.
Publicado: (2018)

Infiltrative Lymphoma-Associated Bradycardia and Cardiac Conduction Abnormalities
por: Subramanyam, Pritha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i2rte3p7nl9npctam40v0ov1hg